Vimta Labs reports 10% YoY growth in Q3 FY26, PAT margins hold at 17.5%
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
The opening of our 1000th pharmacy in Karnataka marks an important step
The ten-day initiative, running from 10 to 21 November, brings together a team of highly skilled German doctors providing life-changing reconstructive surgeries at no cost
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
Several technologies for hemoglobinopathies are being transferred to commercial partners
BIL also holds an option to increase its equity stake by an additional 15%
Subscribe To Our Newsletter & Stay Updated